Clinical Research
Total Trials
4
As Lead Sponsor
0
As Collaborator
Total Enrollment
377
NCT02826798
Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
Phase: Phase 1
Role: Collaborator
Start: Jun 23, 2016
Completion: Aug 24, 2017
NCT04161482
An Open Label Study to Evaluate the Impact of Duration of Subcutaneous Infusion of a Novel, pH Neutral Formulation of Furosemide (Furoscix®) on Safety and Local Skin Tolerability
Start: Dec 2, 2019
Completion: Jun 26, 2020
NCT04529239
Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System
Phase: N/A
Start: Aug 31, 2020
Completion: Mar 1, 2022
NCT04612283
NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain
Phase: Phase 2/3
Start: Oct 31, 2020
Completion: Jan 25, 2022
Loading map...